484 studies on Insulin curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Developing long-acting GLP-1 receptor agonists is paramount for improving patient adherence and convenience in the long-term management of Type 2 Diabetes. If LAPS-Exendin (HM11260C) demonstrates favorable safety and …
This study is significant because it investigates strategies to improve the long-term management of Type 2 Diabetes, moving beyond conventional insulin regimens. The expected findings suggest that combining insulin wi…
Treatment with Cagrilintide resulted in profound and statistically significant reductions in body weight and substantial improvements across multiple metabolic markers. > The high-dose Cagrilintide group exhibited a r…
The development of Amylin-LP1 represents a significant advancement in the therapeutic landscape for metabolic disorders, offering a potent and well-tolerated option. Its long-acting profile could greatly enhance patie…
The ability of Tesamorelin to specifically reduce visceral fat represents a significant advancement in managing HIV-associated lipodystrophy, a condition that severely impacts quality of life and metabolic health. Thi…
The successful outcome of this trial could represent a paradigm shift in managing the complex interplay of Type 1 Diabetes and obesity. If Tirzepatide proves safe and effective, it could offer a novel therapeutic opti…
The meta-analysis revealed significant improvements in metabolic parameters among kidney transplant recipients treated with GLP-1 RAs. Patients experienced a mean weight loss of 4.5 kg (p<0.001) and a reduction in HbA…
Preserving lean body mass during weight loss is crucial for maintaining metabolic health, physical strength, and preventing conditions like sarcopenia (age-related muscle loss). If successful, this study could provide…
If successful, this trial could identify a novel dietary supplement, AMPK Charge+®, that effectively improves glycemic control in individuals with prediabetes or Type 2 Diabetes. The potential for AMPK Charge+® to enh…
This study is crucial for understanding how lifestyle interventions like endurance exercise can complement pharmacological treatments such as semaglutide in managing Type 2 Diabetes. The key implication is that a comb…
The findings of this study compellingly demonstrated that <b>electroacupuncture</b> treatment conferred a <b>significant</b> and <b>robust</b> alleviation of <b>learning</b> and <b>memory impairment</b> in the <b>post…
This case reinforces the critical importance of considering drug-induced pancreatitis in patients presenting with acute abdominal pain while on GLP-1 receptor agonists like Semaglutide. It highlights that even at stan…
This study provides crucial initial evidence that KN069's novel dual mechanism—acting as a GLP-1R (glucagon-like peptide-1 receptor) agonist (mimicking a hormone that promotes insulin release and reduces appetite) and…
This research highlights the profound benefits of GLP-1 receptor agonist therapy in adolescents with obesity, demonstrating not just weight reduction but a critical improvement in body composition by preferentially re…
The completion of this large Phase 3 trial is a significant milestone, as it represents a robust effort to explore a novel therapeutic avenue for Alzheimer's disease. If the results demonstrate a positive effect, it c…
This study is significant because Tirzepatide could offer a novel therapeutic strategy for managing endometrial intra-epithelial neoplasia (EIN) and early-stage endometrial cancer, particularly in obese women. Given t…
This research provides crucial, granular insights into the stability and efficacy of Salcaprozate Sodium as an oral absorption enhancer under diverse physiological conditions. Understanding how various GI factors affe…
This comprehensive toxicological profile provides a crucial foundation for understanding the safety landscape of existing anti-diabetic drugs and informing the development of safer next-generation therapies. The ident…
This case highlights a potential adverse dermatological reaction to tirzepatide, suggesting that GLP-1/GIP receptor agonists might, in rare instances, trigger or exacerbate autoimmune conditions like psoriasis. This o…
This review highlights Tirzepatide's potential as a valuable adjunct therapy for managing the complex challenges of Type 1 Diabetes complicated by overweight or obesity. The dual benefits of improved glycemic control …
Preserving lean muscle mass during rapid weight loss is critical for maintaining metabolic rate, improving insulin sensitivity, and preventing weight regain, especially in individuals with Type 2 Diabetes Mellitus. Th…
This study provides compelling evidence that tirzepatide, a dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, is significantly more effective than semaglutid…
This case report highlights the potential efficacy and safety of GLP-1 receptor agonists (GLP1RAs), specifically semaglutide, in managing the challenging glycemic control associated with mitochondrial diabetes in pedi…
This review highlights a paradigm shift in how dysglycemia might be managed in acute care settings. If GLP-1 RAs prove safe and effective in this population, they could offer a novel therapeutic strategy to improve ou…
If the results demonstrate a positive safety and efficacy profile, this study could pave the way for a novel adjunctive treatment strategy for a particularly challenging patient population. Adults with Type 1 Diabetes…
This study provides compelling evidence that PPARγ and GLP1 receptor agonists can directly improve brain metabolism and neuronal mitochondrial function, offering a novel therapeutic avenue for cognitive health. The us…
This highly sensitive RT-QuIC assay represents a significant advancement in detecting insulin protein misfolding. The ability to detect misfolded insulin at extremely low concentrations and with high specificity could…
This research underscores the significant potential of microalgae as a sustainable and scalable bioreactor for producing novel therapeutic peptides with antidiabetic properties. The identification of potent hypoglycae…
This review highlights the significant potential of GLP-1 RAs as a novel adjunctive therapy for Cystic Fibrosis, offering benefits beyond their established role in diabetes management. Their pleiotropic effects could …
This study holds significant promise for improving the lives of individuals with Type 1 Diabetes. If successful, the combination of a GLP-1 receptor agonist and an SGLT2 inhibitor with AID could offer a novel and high…
These findings highlight capsaicin as a promising therapeutic candidate for managing insulin resistance-induced prostatic hyperplasia, offering a natural compound approach to a widespread health issue. By modulating I…
This research significantly expands our fundamental understanding of how amphiphilic dendrons function as synthetic chaperones, particularly their precise holdase mechanism. The ability of dendron 2 to robustly preven…
This review underscores the critical role of ER stress as a druggable target for a wide array of human diseases, moving beyond its traditional understanding as merely a cellular dysfunction. By consolidating evidence …
This landmark study provides compelling evidence that Tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, offers substantial cardiovascular prot…
The findings suggest that IGF-1 supplementation could be a safe and effective strategy for preventing severe ROP in extremely premature infants, potentially mitigating the devastating visual outcomes associated with t…
This study highlights Costus speciosus as a promising natural compound with multi-target therapeutic potential for Polycystic Ovary Syndrome, addressing both hormonal and metabolic dysfunctions. The significant improv…
This study is crucial because it seeks to uncover a novel mechanism by which semaglutide promotes weight loss, specifically through its impact on brown adipose tissue (BAT). Understanding this pathway could lead to mo…
Optimizing early T2DM management is crucial for preventing long-term complications and improving patient quality of life. This trial could provide critical evidence for the benefits of aggressive, early combination th…
This trial is crucial because it seeks to establish tirzepatide as a novel therapeutic option specifically for the reproductive and metabolic challenges faced by women with PCOS. If successful, the findings could sign…
Understanding tirzepatide's effects on skeletal muscle is critically important, as preserving muscle mass during weight loss is a key challenge, especially in obesity. If tirzepatide can mitigate muscle loss or even i…
This study is crucial for understanding Tirzepatide's long-term efficacy and safety outside of highly controlled clinical trial environments. If successful, the findings could significantly inform clinical guidelines …
This study provides compelling evidence that tirzepatide, when added to basal insulin, offers a highly effective strategy for achieving robust glycemic control and significant weight loss in Chinese patients with Type…
This research demonstrates a significant advancement in islet transplantation therapy by providing a protective and functional microenvironment for pancreatic islets. The biomimetic GelMA scaffolds not only enhance is…
This research highlights a novel mechanistic link between Aβ pathology, IGF1R nuclear signaling, and aberrant cell cycle re-entry in Alzheimer's disease. Understanding this pathway could open new avenues for therapeut…
This novel evidence strongly suggests that tirzepatide could represent a groundbreaking therapeutic strategy for cocaine use disorder (CUD). Its dual action on GLP-1 and GIP receptors appears to modulate reward pathwa…
Semaglutide is currently not FDA-approved for Type 1 Diabetes, making this research critical for exploring new therapeutic avenues in a population with significant unmet medical needs. If the trial demonstrates positi…